COVID-19 and myeloma clinical research - experience from the CARDAMON clinical trial

Br J Haematol. 2021 Jan;192(1):e14-e16. doi: 10.1111/bjh.17168. Epub 2020 Nov 21.
No abstract available

Keywords: COVID-19; clinical trials; myeloma.

Publication types

  • Adaptive Clinical Trial
  • Clinical Trial, Phase II
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 / complications*
  • Cyclophosphamide / therapeutic use
  • Dexamethasone / therapeutic use
  • Humans
  • Multiple Myeloma / complications
  • Multiple Myeloma / therapy*
  • Oligopeptides / therapeutic use
  • Stem Cell Transplantation*

Substances

  • Oligopeptides
  • carfilzomib
  • Dexamethasone
  • Cyclophosphamide